Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
MGMT promoter methylation level in newly diagnosed low-grade glioma is a predictor of hypermutation at recurrence. [electronic resource] by
- Mathur, Radhika
- Zhang, Yalan
- Grimmer, Matthew R
- Hong, Chibo
- Zhang, Michael
- Bollam, Saumya
- Petrecca, Kevin
- Clarke, Jennifer
- Berger, Mitchel S
- Phillips, Joanna J
- Oberheim-Bush, Nancy Ann
- Molinaro, Annette M
- Chang, Susan M
- Costello, Joseph F
Producer: 20210316
In:
Neuro-oncology vol. 22
Availability: No items available.
|
|
12.
|
The kinases IKBKE and TBK1 regulate MYC-dependent survival pathways through YB-1 in AML and are targets for therapy. [electronic resource] by
- Liu, Suhu
- Marneth, Anna E
- Alexe, Gabriela
- Walker, Sarah R
- Gandler, Helen I
- Ye, Darwin Q
- Labella, Katherine
- Mathur, Radhika
- Toniolo, Patricia A
- Tillgren, Michelle
- Gokhale, Prafulla C
- Barbie, David
- Mullally, Ann
- Stegmaier, Kimberly
- Frank, David A
Producer: 20190924
In:
Blood advances vol. 2
Availability: No items available.
|